<< Court reverses the summary judgement decision on ANDA Patent litigation between Ortho McNeil and Caraco Pharmaceutical Laboratories | Weight loss competition to be held to bring a new focus on healthy living >>
Read in | English | Русский

Global Markets Direct's new report on Spinal Fusion Clinical Trial Analysis

Published on August 29, 2009 at 4:35 AM · No Comments

Research and Markets (http://www.researchandmarkets.com/research/407e32/spinal_fusion_clin) has announced the addition of Global Markets Direct's new report "Spinal Fusion Clinical Trial Analysis" to their offering.

Global Markets Direct's "Spinal Fusion Clinical Trials Analysis" is an essential source of data and information pertaining to product clinical trials being carried out by Spinal Fusion manufacturers, globally. The report provides exhaustive information on each clinical investigation study with coverage detailed coverage on the pipeline products these trials are being carried out for.

Scope:

  • The report provides analysis and review of the key clinical trials being carried out globally and across key Spinal Fusion market categories - Pedicle Screws, Interbody Cages
  • The report covers information on each product being clinically tested with detailed coverage on the pipeline product profile, the indication it's being investigated for etc.
  • The report provides an in-depth analysis of the clinical trials with information on trial phase, trial 0status, trial acronym, purpose, inclusion and exclusion criteria, description, design, intervention, investigator information, primary and secondary end-points and trial results
  • The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by Global Markets Direct's team of industry experts.

Reasons to Buy:

  • Effectively plan your Mergers and Acquisitions and partnership strategies by identifying companies with the most promising pipeline.
  • Stay ahead of the information curve in the fast changing Spinal Fusion market.
  • Plan in-licensing and out-licensing opportunities through review of pipeline products and technologies.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Proactively plan and execute your competitive strategies by identifying clinical trials status of the leading competitive products in pipeline.
  • Stay ahead of competition by understanding the changing competitive landscape in specific geographies.

 http://www.researchandmarkets.com/

 

Posted in: Drug Trial News

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading